TCS 2314 (compound 3) 是一种具有口服活性、选择性的极迟抗原 4(VLA-4, α4β1, CD49d/CD29)拮抗剂，其IC50为 4.4 nM。
| 生物活性 | TCS 2314 (compound 3) is orally active and selectivevery late antigen-4 (VLA-4,α4β1, CD49d/CD29)antagonist with anIC50of 4.4 nM[1]. |
| IC50& Target | IC50: 4.4 nM (Very late antigen-4)[1] |
| 分子量 | |
| 性状 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | | Powder | -20°C | 3 years | | 4°C | 2 years | | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
